shortagewatch

Home / Companies / Sanis

Company family · HQ CA

Sanis: medicine shortages

private (Loblaw)

As of 2 Nov 2026, 98 Sanis products have a reported shortage across 1 countries, covering 54 medicines.

Products short98rank #20 of 464
Medicines54active ingredients
Countries1/16
New in 90 days16-11 vs market pace
Typical duration11 monthsmedian so far
Manufacturing95%demand-driven 3%

Where

Canada98

Which therapeutic classes

Nervous system29Cardiovascular system29Digestive tract and metabolism19Genito-urinary system and sex hormones11Anti-infectives4Respiratory system2Blood1Musculoskeletal system1Sensory organs1Dermatologicals1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
SanisSanis: Manufacturing problem 86 (88%)88%Sanis: Increased demand 3 (3%)Sanis: Other 2 (2%)Sanis: Not stated 7 (7%)7%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

025710Dec: 1Jan ’25: 0Feb: 0FebMar: 2Apr: 1May: 0MayJun: 0Jul: 0Aug: 2AugSep: 1Oct: 0Nov: 0NovDec: 8Jan ’26: 1Feb: 0FebMar: 1Apr: 4May: 7MayJun: 2Jul: 6Aug: 6AugSep: 3Oct: 7Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0501001502002017: 4020172018: 4720182019: 7620192020: 5620202021: 4220212022: 1620222023: 8220232024: 17920242025: 9720252026: 6720262027: 22027

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Sanis98

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Sanis: 98 / 54Sanis

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Candesartan69 Apr 2024Manufacturing problem10/16
Quetiapine513 Apr 2024Manufacturing problem12/16
Terazosin4not givenNot stated4/16
Atenolol38 Apr 2026Manufacturing problem6/16
Furosemide38 Dec 2025Manufacturing problem11/16
Irbesartan and Diuretics31 Jun 2024Manufacturing problem4/16
Pantoprazole311 Nov 2024Manufacturing problem9/16
Ramipril38 Dec 2025Manufacturing problem10/16
Tadalafil313 Jul 2026Manufacturing problem10/16
Topiramate313 Jul 2026Manufacturing problem8/16
Amoxicillin212 Jul 2022Increased demand7/16
Atorvastatin225 May 2026Manufacturing problem11/16
Betahistine25 Nov 2024Manufacturing problem5/16
Diltiazem25 Aug 2026Manufacturing problem7/16
Escitalopram25 Aug 2026Manufacturing problem10/16
Esomeprazole211 Aug 2025Manufacturing problem9/16
Gabapentin223 Aug 2024Manufacturing problem9/16
Gliclazide21 Nov 2024Increased demand8/16
Lansoprazole225 May 2026Manufacturing problem8/16
Metoprolol23 Sep 2025Manufacturing problem9/16
Montelukast218 Apr 2019Manufacturing problem13/16
Morphine2not givenNot stated8/16
Olanzapine222 Jan 2027Manufacturing problem13/16
Rabeprazole214 Sep 2026Manufacturing problem5/16
Ranitidine216 Sep 2019Manufacturing problem1/16
Simvastatin215 Jul 2026Manufacturing problem9/16
Ursodeoxycholic Acid212 Jul 2024Manufacturing problem7/16
Zolmitriptan211 Sep 2024Manufacturing problem4/16
Acetylsalicylic Acid118 Nov 2024Manufacturing problem4/16
Acetylsalicylic Acid110 Mar 2025Manufacturing problem7/16
Buspirone117 Dec 2025Other1/16
Celecoxib15 Oct 2026Manufacturing problem8/16
Citalopram120 Nov 2026Manufacturing problem5/16
Clarithromycin120 Jul 2022Manufacturing problem5/16
Domperidone18 Dec 2025Manufacturing problem5/16
Duloxetine1not givenNot stated12/16
Dutasteride15 Oct 2026Manufacturing problem4/16
Ezetimibe15 Jun 2026Manufacturing problem9/16
Famotidine125 May 2026Manufacturing problem4/16
Fluconazole15 Oct 2026Manufacturing problem12/16
Glibenclamide125 May 2026Manufacturing problem2/16
Hydrochlorothiazide116 May 2024Manufacturing problem3/16
Lisinopril and Diuretics118 Aug 2026Manufacturing problem3/16
Memantine125 May 2026Manufacturing problem8/16
Moxifloxacin15 Aug 2026Manufacturing problem1/16
Omeprazole118 Nov 2024Manufacturing problem8/16
Pregabalin19 Oct 2026Manufacturing problem11/16
Progesterone15 May 2026Manufacturing problem5/16
Sertraline125 May 2026Other11/16
Solifenacin19 Sep 2024Manufacturing problem6/16
Sumatriptan120 Nov 2026Manufacturing problem13/16
Tamsulosin118 Nov 2024Manufacturing problem6/16
Terbinafine115 Oct 2024Manufacturing problem5/16
Trazodone18 Dec 2025Manufacturing problem3/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.